O blood usage trends in the pediatric population 2015-2019: A multi-institutional analysis

K Annen1,2, S Andani2, G Bosma3

  • 1Children's Hospital Colorado, Aurora, Colorado, USA.

Transfusion
|March 28, 2025
PubMed

Insights

Pediatric transfusions often use group O red blood cells even for non-O patients. This study identified key patient groups, like those with cardiovascular disorders and sickle cell anemia, receiving group O blood, offering insights for blood supply management.

Area of Science:

  • Transfusion Medicine
  • Pediatric Hematology
  • Blood Banking

Background:

  • Limited 2019 AABB recommendations on group O red blood cell use in pediatrics.
  • Eight U.S. pediatric hospitals investigated trends in group O blood usage.
  • Focus on identifying pediatric populations receiving group O blood despite non-group O blood type.

Purpose of the Study:

  • To analyze pediatric transfusion practices regarding group O red blood cells.
  • To clarify which pediatric patient groups receive group O blood transfusions when their blood type is non-O.
  • To inform strategies for optimizing blood supply and transfusion safety in children.

Main Methods:

  • Retrospective analysis of Electronic Health Records from eight pediatric institutions.
  • Inclusion of data on unit and patient blood type, age, sex, and diagnosis.
  • Utilized GPT-4 for diagnosis categorization and visualized data with alluvial plots, spaghetti plots, and stratified tables.

Main Results:

  • 142,227 transfusion events analyzed; 52,731 recipients had non-O blood types.
  • 67% of group O blood transfusions were given to A, B, or AB blood type recipients.
  • Cardiovascular disorders (22%) and sickle cell anemia (15%) were top diagnostic categories for group O blood recipients.

Conclusions:

  • Significant utilization of group O blood in non-O pediatric patients identified.
  • Opportunities exist to safely use non-O blood in specific pediatric populations.
  • Findings can help address challenges in maintaining an adequate group O red blood cell supply.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Blood Transfusion01:15

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...